India's own first drug - from Biocon.
...iotechnology firm, launched its second novel 'lab-to-market' molecule, Alzumab, to treat chronic plaque psor...t a cost 50 per cent lower than the existing one. Biocon is bringing Alzumab (a biologic) in the form of a...3904 days ago
India's own first drug - from Biocon.
Psoriasis is immune-mediated disease that effects the skin. the Disease on an average affects about 10-20 million Indians and it attacks the immune system of human beings. In generally occurs, when the immune system mistakes a normal skin cell for a pathogen, and sends out faulty signals that cau...Tags: Psoriasis, Alzumab, Genotypic, Genomics, India, Biocon
3904 days ago
Comment on "India's own first drug - from Biocon."
Alzumab is the "the world’s first anti-CD6 antibody drug" for treating psoriasis.3901 days ago